Serine 9 and tyrosine 216 phosphorylation of gsk-3β differentially regulates autophagy in acquired cadmium resistance

Toxicological Sciences

Volumn 135, Issue 2, 2013, Pages 380-389

  Park, Chung Hyun ^a   Lee, Byung Hoon ^b   Ahn, Sang Gun ^c,d   Yoon, Jung Hoon ^c   Oh, Seon Hee ^a,c,d  

^a Cha University   (South Korea)

^b Seoul National University   (South Korea)

^c Chosun University   (South Korea)

^d Wonkwang University   (South Korea)

Author keywords

Autophagy; Cadmium; Glycogen synthase kinase 3; Lung; Resistance

Indexed keywords

3 METHYLADENINE; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; BETA CATENIN; CADMIUM; GENISTEIN; GLYCOGEN SYNTHASE KINASE 3ALPHA; GLYCOGEN SYNTHASE KINASE 3BETA; LITHIUM; OKADAIC ACID; PHOSPHATIDYLINOSITOL 3 KINASE INHIBITOR; PROCASPASE 3; PROTEIN; PROTEIN BAX; PROTEIN LC3 II; SERINE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOPHAGY; CARCINOMA CELL; CELL CYCLE G1 PHASE; CELL NUCLEUS; CELL VIABILITY; CONTROLLED STUDY; CYTOPLASM; DOWN REGULATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; LONG TERM EXPOSURE; LUNG PARENCHYMA; MALE; MOUSE; NONHUMAN; PHYSICAL RESISTANCE; PROTEIN CLEAVAGE; REGULATORY MECHANISM;

AUTOPHAGY; CADMIUM; GLYCOGEN SYNTHASE KINASE-3; LUNG.; RESISTANCE;

AGED; ANIMALS; AUTOPHAGY; CADMIUM; CELL LINE, TUMOR; GLYCOGEN SYNTHASE KINASE 3; HUMANS; INDOLES; MALE; MALEIMIDES; MICE; MICE, INBRED C57BL; PHOSPHORYLATION; SERINE; TYROSINE;

EID: 84886651582     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kft158     Document Type: Article

References (50)

1. Bhat, R. V., Shanley, J., Correll, M. P., Fieles, W. E., Keith, R. A., Scott, C. W., and Lee, C. M. (2000). Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3beta in cellular and animal models of neuronal degeneration. Proc. Natl. Acad. Sci. U.S.A. 97, 11074-11079.
2. Bijur, G. N., and Jope, R. S. (2003). Glycogen synthase kinase-3 beta is highly activated in nuclei and mitochondria. Neuroreport 14, 2415-2419.
3. Choi, C. H., Jung, Y. K., and Oh, S. H. (2010). Autophagy induction by capsaicin in malignant human breast cells is modulated by p38 and extracellular signal-regulated mitogen-activated protein kinases and retards cell death by suppressing endoplasmic reticulum stress-mediated apoptosis. Mol. Pharmacol. 78, 1-12.
4. Codogno, P. (2005). Autophagy in cell survival and death. J. Soc. Biol. 199, 233-241.
5. Coghlan, M. P., Culbert, A. A., Cross, D. A., Corcoran, S. L., Yates, J. W., Pearce, N. J., Rausch, O. L., Murphy, G. J., Carter, P. S., Roxbee Cox, L., MIlls, D., Brown, M. J., Haigh, D., Ward, R. W., Smith, D. G., Murray, K. J., Reith, A. D., and Holder, J. C. (2000). Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription. Chem. Biol. 7, 793-803.
6. Cole, A., Frame, S., and Cohen, P. (2004). Further evidence that the tyrosine phosphorylation of glycogen synthase kinase-3 (GSK3) in mammalian cells is an autophosphorylation event. Biochem. J. 377, 249-255.
7. Crowder, R. J., and Freeman, R. S. (2000). Glycogen synthase kinase-3 beta activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal. J. Biol. Chem. 275, 34266-34271.
8. Diehl, J. A., Cheng, M., Roussel, M. F., and Sherr, C. J. (1998). Glycogen synthase kinase-3beta regulates cyclin D1 proteolysis and subcellular localization. Genes Dev. 12, 3499-3511.
9. Eldar-Finkelman, H. (2002). Glycogen synthase kinase 3: An emerging therapeutic target. Trends Mol. Med. 8, 126-132.
10. Forde, J. E., and Dale, T. C. (2007). Glycogen synthase kinase 3: A key regulator of cellular fate. Cell. Mol. Life Sci. 64, 1930-1944.
11. Gobe, G., and Crane, D. (2010). Mitochondria, reactive oxygen species and cadmium toxicity in the kidney. Toxicol. Lett. 198, 49-55.
12. Goyer, R. A. (1991). Transplacental transfer of cadmium and fetal effects. Fundam. Appl. Toxicol. 16, 22-23.
13. Goyer, R. A., Liu, J., and Waalkes, M. P. (2004). Cadmium and cancer of prostate and testis. Biometals 17, 555-558
14. Hartigan, J. A., Xiong, W. C., and Johnson, G. V. (2001). Glycogen synthase kinase 3beta is tyrosine phosphorylated by PYK2. Biochem. Biophys. Res. Commun. 284, 485-489.
15. Hetman, M., Cavanaugh, J. E., Kimelman, D., and Xia, Z. (2000). Role of glycogen synthase kinase-3beta in neuronal apoptosis induced by trophic withdrawal. J. Neurosci. 20, 2567-2574.
16. Hoeflich, K. P., Luo, J., Rubie, E. A., Tsao, M. S., Jin, O., and Woodgett, J. R. (2000). Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation. Nature 406, 86-90.
17. Huang, C., Zhang, Q., Li, J., Shi, X., Castranova, V., Ju, G., Costa, M., and Dong, Z. (2001). Involvement of Erks activation in cadmium-induced AP-1 transactivation in vitro and in vivo. Mol. Cell. Biochem. 222, 141-147.
18. Huang, J., Ni, J., Liu, K., Yu, Y., Xie, M., Kang, R., Vernon, P., Cao, L., and Tang, D. (2012). HMGB1 promotes drug resistance in osteosarcoma. Cancer Res. 72, 230-238.
19. Hughes, K., Nikolakaki, E., Plyte, S. E., Totty, N. F., and Woodgett, J. R. (1993). Modulation of the glycogen synthase kinase-3 family by tyrosine phosphorylation. EMBO J. 12, 803-808.
20. IARC. (1993). Beryllium, cadmium, mercury, and exposures in the glass manufacturing industry. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. 58, 1-415.
21. Jin, P., and Ringertz, N. R. (1990). Cadmium induces transcription of protooncogenes c-jun and c-myc in rat L6 myoblasts. J. Biol. Chem. 265, 14061-14064.
22. Kim, K. J., Moon, S. M., Kim, S. A., Kang, K. W., Yoon, J. H., and Ahn, S. G. (2012). Transcriptional regulation of MDR-1 by HOXC6 in multidrugresistant cells. Oncogene; e-pub ahead of print 20 August 2012; doi:10.1038/ onc.2012.354.
23. Kim, L., Liu, J., and Kimmel, A. R. (1999). The novel tyrosine kinase ZAK1 activates GSK3 to direct cell fate specification. Cell 99, 399-408.
24. Klein, P. S., and Melton, D. A. (1996). A molecular mechanism for the effect of lithium on development. Proc. Natl. Acad. Sci. U.S.A. 93, 8455-8459.
25. Lau, A. T., and Chiu, J. F. (2007). The possible role of cytokeratin 8 in cadmium-induced adaptation and carcinogenesis. Cancer Res. 67, 2107-2113.
26. Lau, A. T., Zhang, J., and Chiu, J. F. (2006). Acquired tolerance in cadmiumadapted lung epithelial cells: Roles of the c-Jun N-terminal kinase signaling pathway and basal level of metallothionein. Toxicol. Appl. Pharmacol. 215, 1-8.
27. Lesort, M., Jope, R. S., and Johnson, G. V. (1999). Insulin transiently increases tau phosphorylation: Involvement of glycogen synthase kinase-3beta and Fyn tyrosine kinase. J. Neurochem. 72, 576-584.
28. Liang, C., Li, H., Shen, C., Lai, J., Shi, Z., Liu, B., and Tao, H. M. (2012). Genistein potentiates the anti-cancer effects of gemcitabine in human osteosarcoma via the downregulation of Akt and nuclear factor-κB pathway. Anticancer Agents Med. Chem. 12, 554-563.
29. Meijer, L., Flajolet, M., and Greengard, P. (2004). Pharmacological inhibitors of glycogen synthase kinase 3. Trends Pharmacol. Sci. 25, 471-480.
30. Miller, J. R., and Moon, R. T. (1996). Signal transduction through betacatenin and specification of cell fate during embryogenesis. Genes Dev. 10, 2527-2539.
31. Mizushima, N., Yoshimori, T., and Levine, B. (2010). Methods in mammalian autophagy research. Cell 140, 313-326.
32. Noël, A., Barrier, L., Rinaldi, F., Hubert, C., Fauconneau, B., and Ingrand, S. (2011). Lithium chloride and staurosporine potentiate the accumulation of phosphorylated glycogen synthase kinase 3β/Tyr216, resulting in glycogen synthase kinase 3β activation in SH-SY5Y human neuroblastoma cell lines. J. Neurosci. Res. 89, 755-763.
33. Oh, S. H., Lee, B. H., and Lim, S. C. (2004). Cadmium induces apoptotic cell death in WI 38 cells via caspase-dependent Bid cleavage and calpainmediated mitochondrial Bax cleavage by Bcl-2-independent pathway. Biochem. Pharmacol. 68, 1845-1855.
34. Oh, S. H., Lee, S. Y., Choi, C. H., Lee, S. H., and Lim, S. C. (2009). Cadmium adaptation is regulated by multidrug resistance-associated protein-mediated Akt pathway and metallothionein induction. Arch. Pharm. Res. 32, 883-891.
35. Ouyang, L., Shi, Z., Zhao, S., Wang, F. T., Zhou, T. T., Liu, B., and Bao, J. K. (2012). Programmed cell death pathways in cancer: A review of apoptosis, autophagy and programmed necrosis. Cell Prolif. 45, 487-498.
36. Pap, M., and Cooper, G. M. (1998). Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-Kinase/Akt cell survival pathway. J. Biol. Chem. 273, 19929-19932.
37. Qu, W., Fuquay, R., Sakurai, T., and Waalkes, M. P. (2006). Acquisition of apoptotic resistance in cadmium-induced malignant transformation: Specific perturbation of JNK signal transduction pathway and associated metallothionein overexpression. Mol. Carcinog. 45, 561-571.
38. Sahin, K., Tuzcu, M., Basak, N., Caglayan, B., Kilic, U., and Sahin, F. (2012). Sensitization of cervical cancer cells to cisplatin by genistein: The role of NFκB and Akt/mTOR signaling pathways. J. Oncol. e-pub ahead of print 27 September 2012; doi:10.1155/2012/461562.
39. Simón, D., Benitez, M. J., Gimenez-Cassina, A., Garrido, J. J., Bhat, R. V., Díaz-Nido, J., and Wandosell, F. (2008). Pharmacological inhibition of GSK-3 is not strictly correlated with a decrease in tyrosine phosphorylation of residues 216/279. J. Neurosci. Res. 86, 668-674.
40. Sirichanchuen, B., Pengsuparp, T., and Chanvorachote, P. (2012). Long-term cisplatin exposure impairs autophagy and causes cisplatin resistance in human lung cancer cells. Mol. Cell. Biochem. 364, 11-18.
41. Song, L., De Sarno, P., and Jope, R. S. (2002). Central role of glycogen synthase kinase-3beta in endoplasmic reticulum stress-induced caspase-3 activation. J. Biol. Chem. 277, 44701-44708.
42. Tan, J., Zhuang, L., Leong, H. S., Iyer, N. G., Liu, E. T., and Yu, Q. (2005). Pharmacologic modulation of glycogen synthase kinase-3beta promotes p53-dependent apoptosis through a direct Bax-mediated mitochondrial pathway in colorectal cancer cells. Cancer Res. 65, 9012-9020.
43. Vlahos, C. J., Matter, W. F., Hui, K. Y., and Brown, R. F. (1994). A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 269, 5241-5248.
44. Waalkes, M. P. (2003). Cadmium carcinogenesis. Mutat. Res. 533, 107-120.
45. Wang, S. H., Shih, Y. L., Kuo, T. C., Ko, W. C., and Shih, C. M. (2009). Cadmium toxicity toward autophagy through ROS-activated GSK-3beta in mesangial cells. Toxicol. Sci. 108, 124-131.
46. Wang, Z., and Templeton, D. M. (1998). Induction of c-fos proto-oncogene in mesangial cells by cadmium. J. Biol. Chem. 273, 73-79.
47. Xu, G., Zhou, G., Jin, T., Zhou, T., Hammarström, S., Bergh, A., and Nordberg, G. (1999). Apoptosis and p53 gene expression in male reproductive tissues of cadmium exposed rats. Biometals 12, 131-139.
48. Yang, J., Takahashi, Y., Cheng, E., Liu, J., Terranova, P. F., Zhao, B., Thrasher, J. B., Wang, H. G., and Li, B. (2010). GSK-3beta promotes cell survival by modulating Bif-1-dependent autophagy and cell death. J. Cell Sci. 12, 861-870.
49. Yang, L., Yu, Y., Kang, R., Yang, M., Xie, M., Wang, Z., Tang, D., Zhao, M., Liu, L., Zhang, H., and Cao, L. (2012). Up-regulated autophagy by endogenous high mobility group box-1 promotes chemoresistance in leukemia cells. Leuk. Lymphoma 53, 315-322.
50. Yoon, J. H., Ahn, S. G., Lee, B. H., Jung, S. H., and Oh, S. H. (2010). Role of autophagy in chemoresistance: Regulation of the ATM-mediated DNAdamage signaling pathway through activation of DNA-PKcs and PARP-1. Biochem. Pharmacol. 83, 747-757.